Back to Feed
总结
在美国旧金山举行的摩根大通医疗健康大会（JPM）临近，媒体预计制药与生物科技公司将集中发布业绩指引、研发管线进展与潜在并购合作信号，投资人也将借机评估行业在此前融资与估值承压后的修复力度。报道同时指出，药价改革、监管取向与美国政治因素将贯穿会议讨论，并影响交易活跃度及市场情绪。
正文
Healthy Returns: What to expect from pharma at the JPM conference CNBC JPM to bring more deals and happy CEOs statnews.com At JPM26, Policy and Politics Will Loom Large for Pharma as Biotech Sees the Sun BioSpace JPM 2026: What to know about the San Francisco conference Modern Healthcare News Will biotech's big JPM conference signal a new normal for the industry and San Francisco? The Business Journals
发布时间：